Results 21 to 30 of about 47,897 (254)

Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: Prevention by lipoic acid treatment

open access: yesBMC Nephrology, 2006
Background A reduction in the number of podocytes and podocyte density has been documented in the kidneys of patients with diabetes mellitus. Additional studies have shown that podocyte injury and loss occurs in both diabetic animals and humans. However,
Sullivan Kelli A   +4 more
doaj   +1 more source

Traditional Chinese Medicine in Treating Primary Podocytosis: From Fundamental Science to Clinical Research

open access: yesFrontiers in Pharmacology, 2022
Podocytes form a key component of the glomerular filtration barrier. Damage to podocytes is referred to as “podocyte disease.” There are many causes of podocyte injury, including primary injury, secondary injury, and gene mutations.
Lirong Lin   +5 more
doaj   +1 more source

Whole carcass diets: a role for fibre in gastrointestinal health of cheetahs? [PDF]

open access: yes, 2011
This study was undertaken to test the hypothesis that altered podocyte slit protein nephrin distribution is associated with disturbed polarity protein expressions in podocytes from preeclampsia (PE).
Depauw, Sarah   +6 more
core   +2 more sources

Erk5 is a mediator to TGFβ1-induced loss of phenotype and function in human podocytes. [PDF]

open access: yes, 2014
Background: Podocytes are highly specialized cells integral to the normal functioning kidney, however, in diabetic nephropathy injury occurs leading to a compromised phenotype and podocyte dysfunction which critically produces podocyte loss with ...
Binder   +39 more
core   +2 more sources

Receptor-mediated endocytosis of α-galactosidase A in human podocytes in Fabry disease. [PDF]

open access: yesPLoS ONE, 2011
Injury to the glomerular podocyte is a key mechanism in human glomerular disease and podocyte repair is an important therapeutic target. In Fabry disease, podocyte injury is caused by the intracellular accumulation of globotriaosylceramide.
Thaneas Prabakaran   +8 more
doaj   +1 more source

Redox signaling, Nox5 and vascular remodeling in hypertension [PDF]

open access: yes, 2015
Purpose of review: Extensive data indicate a role for reactive oxygen species (ROS) and redox signaling in vascular damage in hypertension. However, molecular mechanisms underlying these processes remain unclear, but oxidative post-translational ...
De Lucca Camargo, Livia   +5 more
core   +1 more source

Cryoglobulinaemic vasculitis: classification and clinical and therapeutic aspects [PDF]

open access: yes, 2007
Cryoglobulinaemia may cause cutaneous vasculitis and glomerulonephritis, potentially leading to end stage renal failure. An important proportion of cryoglobulinaemias are secondary to hepatitis C virus infection.
Braun, Gerald S.   +4 more
core   +2 more sources

Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease. [PDF]

open access: yes, 2006
BackgroundGlomerular basement membrane (GBM), a key component of the blood-filtration apparatus in the in the kidney, is formed through assembly of type IV collagen with laminins, nidogen, and sulfated proteoglycans.
Cosgrove, Dominic   +8 more
core   +3 more sources

Urinary excretion of RAS, BMP, and WNT pathway components in diabetic kidney disease. [PDF]

open access: yes, 2014
The renin-angiotensin system (RAS), bone morphogenetic protein (BMP), and WNT pathways are involved in pathogenesis of diabetic kidney disease (DKD).
Afkarian, Maryam   +5 more
core   +1 more source

Receptor activator of NF-kappaB and podocytes: towards a function of a novel receptor-ligand pair in the survival response of podocyte injury. [PDF]

open access: yesPLoS ONE, 2012
BACKGROUND: Glomerulosclerosis correlates with reduction in podocyte number that occurs through mechanisms which include apoptosis. Podocyte injury or podocyte loss in the renal glomerulus has been proposed as the crucial mechanism in the development of ...
Shuangxin Liu   +17 more
doaj   +1 more source

Home - About - Disclaimer - Privacy